Literature DB >> 15953532

The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study.

Marjolein W M van Ruijven1, John C M J de Groot, Sjaak F L Klis, Guido F Smoorenburg.   

Abstract

Cisplatin ototoxicity has at least three major targets in the cochlea: the stria vascularis, the organ of Corti, and the spiral ganglion. This study aims to differentiate between these three targets. In particular, we address the question of whether the effects at the level of the organ of Corti and spiral ganglion are mutually dependent or whether they develop in parallel. This question was approached by studying the ototoxic effects while they develop electrophysiologically and comparing these to earlier presented histological data [Van Ruijven et al., 2004. Hear. Res. 197, 44-54]. Guinea pigs were treated with intraperitoneal injections of cisplatin at a dose of 2 mg/kg/day for either 4, 6, or 8 consecutive days. This time sequence has not revealed any evidence of one ototoxic process triggering another. Therefore, we have to stay with the conclusion of Van Ruijven et al. (2004) that both processes run in parallel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953532     DOI: 10.1016/j.heares.2005.03.023

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  47 in total

1.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

2.  Cisplatin ototoxicity affecting cochlear implant benefit.

Authors:  Michael S Harris; Jaimie L Gilbert; Kelly A Lormore; Swapna A Musunuru; Michael H Fritsch
Journal:  Otol Neurotol       Date:  2011-08       Impact factor: 2.311

3.  The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats.

Authors:  Mehmet Kelles; Mehmet Tan; M Tayyar Kalcioglu; Yuksel Toplu; Nazire Bulam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-11-28

4.  The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach.

Authors:  Sofia Waissbluth; Delphine Garnier; Olubunmi V Akinpelu; Pezhman Salehi; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-23       Impact factor: 2.503

5.  Lovastatin protects against cisplatin-induced hearing loss in mice.

Authors:  Katharine Fernandez; Katie K Spielbauer; Aaron Rusheen; Lizhen Wang; Tiffany G Baker; Stephen Eyles; Lisa L Cunningham
Journal:  Hear Res       Date:  2020-02-06       Impact factor: 3.208

6.  Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.

Authors:  Maryam Fouladi; Murali Chintagumpala; David Ashley; Stewart Kellie; Sridharan Gururangan; Tim Hassall; Lindsey Gronewold; Clinton F Stewart; Dana Wallace; Alberto Broniscer; Gregory A Hale; Kimberly A Kasow; Thomas E Merchant; Brannon Morris; Matthew Krasin; Larry E Kun; James M Boyett; Amar Gajjar
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

7.  Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.

Authors:  Sofia Waissbluth; Pezhman Salehi; Xinying He; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-21       Impact factor: 2.503

Review 8.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

9.  Protective role of bilberry extract against Cisplatin induced ototoxicity in rats.

Authors:  Zeliha Kapusuz; Mahmut Ozkırış; Mehtap Kala; Levent Saydam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-20

10.  Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.

Authors:  Victoria Hellberg; Inger Wallin; Sofi Eriksson; Emma Hernlund; Elin Jerremalm; Maria Berndtsson; Staffan Eksborg; Elias S J Arnér; Maria Shoshan; Hans Ehrsson; Göran Laurell
Journal:  J Natl Cancer Inst       Date:  2008-12-30       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.